NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 318 filers reported holding NATERA INC in Q3 2023. The put-call ratio across all filers is 1.90 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,866,000 | -18.1% | 42,169 | -10.0% | 0.01% | -11.1% |
Q2 2023 | $2,279,000 | -15.5% | 46,841 | -3.5% | 0.01% | -18.2% |
Q1 2023 | $2,696,000 | +34.1% | 48,559 | -3.0% | 0.01% | +22.2% |
Q4 2022 | $2,011,000 | +6.0% | 50,066 | +15.6% | 0.01% | 0.0% |
Q3 2022 | $1,897,000 | +24.6% | 43,299 | +0.8% | 0.01% | +50.0% |
Q2 2022 | $1,522,000 | -13.7% | 42,958 | -0.9% | 0.01% | 0.0% |
Q1 2022 | $1,764,000 | -57.9% | 43,369 | -3.4% | 0.01% | -57.1% |
Q4 2021 | $4,192,000 | -19.3% | 44,889 | -3.6% | 0.01% | -22.2% |
Q3 2021 | $5,192,000 | +2.4% | 46,587 | +4.3% | 0.02% | 0.0% |
Q2 2021 | $5,071,000 | +3214.4% | 44,669 | +2870.0% | 0.02% | +1700.0% |
Q1 2021 | $153,000 | – | 1,504 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 797,436 | $35,286,543 | 33.31% |
Kynam Capital Management, LP | 3,003,668 | $132,912,309 | 21.74% |
Eversept Partners, LP | 2,492,636 | $110,299,143 | 9.33% |
Sofinnova Investments, Inc. | 3,100,560 | $137,199,780 | 8.66% |
Eagle Health Investments LP | 595,694 | $26,359,460 | 5.81% |
BEACONLIGHT CAPITAL, LLC | 259,865 | $11,499,026 | 4.97% |
Lagoda Investment Management, L.P. | 165,465 | $7,321,826 | 4.81% |
Tri Locum Partners LP | 274,795 | $12,159,679 | 3.89% |
Bain Capital Life Sciences Investors, LLC | 700,197 | $30,983,717 | 3.46% |
SAMLYN CAPITAL, LLC | 4,400,226 | $194,710,000 | 3.18% |